Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giorgio Parmiani

Showing results (71-80 of 105) with videos related to

Pageof 11
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 19, 2008
Phase III comparison of vitespen, an autologous tumor-derived heat shock protein gp96 peptide complex vaccine, with physician's choice of treatment for stage IV melanoma: the C-100-21 Study GroupAlessandro Testori, Jon Richards, Eric Whitman, et al.
Cancer Research|February 5, 2008
CCN3/nephroblastoma overexpressed matricellular protein regulates integrin expression, adhesion, and dissemination in melanomaViviana Vallacchi, Maria Daniotti, Francesca Ratti, et al.
International Immunology|May 17, 2003
Naturally occurring peptides associated with HLA-A2 in ovarian cancer cell lines identified by mass spectrometry are targets of HLA-A2-restricted cytotoxic T cellsVenkatesh Ramakrishna, Mark M Ross, Max Petersson, et al.
Cancer Research|October 30, 2003
Antigen-specific immunity in neuroblastoma patients: antibody and T-cell recognition of NY-ESO-1 tumor antigenMonica Rodolfo, Roberto Luksch, Elisabeth Stockert, et al.
The Journal of Experimental Medicine|May 22, 2002
Induction of lymphocyte apoptosis by tumor cell secretion of FasL-bearing microvesiclesGiovanna Andreola, Licia Rivoltini, Chiara Castelli, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 23, 2003
Human tumor-derived heat shock protein 96 mediates in vitro activation and in vivo expansion of melanoma- and colon carcinoma-specific T cellsLicia Rivoltini, Chiara Castelli, Matteo Carrabba, et al.
The Journal of Investigative Dermatology|January 23, 2009
Cutaneous melanoma in childhood and adolescence shows frequent loss of INK4A and gain of KITMaria Daniotti, Andrea Ferrari, Simona Frigerio, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 10, 2003
Vaccination with autologous tumor-derived heat-shock protein gp96 after liver resection for metastatic colorectal cancerVincenzo Mazzaferro, Jorgelina Coppa, Matteo G Carrabba, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 26, 2004
Boosting T cell-mediated immunity to tyrosinase by vaccinia virus-transduced, CD34(+)-derived dendritic cell vaccination: a phase I trial in metastatic melanomaMassimo Di Nicola, Carmelo Carlo-Stella, Roberta Mortarini, et al.
Journal of the National Cancer Institute|November 18, 2004
Effect of proton pump inhibitor pretreatment on resistance of solid tumors to cytotoxic drugsFrancesca Luciani, Massimo Spada, Angelo De Milito, et al.
Pageof 11

Showing results (71-80 of 105) with videos related to

Sort By:
Pageof 11
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 19, 2008
Phase III comparison of vitespen, an autologous tumor-derived heat shock protein gp96 peptide complex vaccine, with physician's choice of treatment for stage IV melanoma: the C-100-21 Study GroupAlessandro Testori, Jon Richards, Eric Whitman, et al.
Cancer Research|February 5, 2008
CCN3/nephroblastoma overexpressed matricellular protein regulates integrin expression, adhesion, and dissemination in melanomaViviana Vallacchi, Maria Daniotti, Francesca Ratti, et al.
International Immunology|May 17, 2003
Naturally occurring peptides associated with HLA-A2 in ovarian cancer cell lines identified by mass spectrometry are targets of HLA-A2-restricted cytotoxic T cellsVenkatesh Ramakrishna, Mark M Ross, Max Petersson, et al.
Cancer Research|October 30, 2003
Antigen-specific immunity in neuroblastoma patients: antibody and T-cell recognition of NY-ESO-1 tumor antigenMonica Rodolfo, Roberto Luksch, Elisabeth Stockert, et al.
The Journal of Experimental Medicine|May 22, 2002
Induction of lymphocyte apoptosis by tumor cell secretion of FasL-bearing microvesiclesGiovanna Andreola, Licia Rivoltini, Chiara Castelli, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 23, 2003
Human tumor-derived heat shock protein 96 mediates in vitro activation and in vivo expansion of melanoma- and colon carcinoma-specific T cellsLicia Rivoltini, Chiara Castelli, Matteo Carrabba, et al.
The Journal of Investigative Dermatology|January 23, 2009
Cutaneous melanoma in childhood and adolescence shows frequent loss of INK4A and gain of KITMaria Daniotti, Andrea Ferrari, Simona Frigerio, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 10, 2003
Vaccination with autologous tumor-derived heat-shock protein gp96 after liver resection for metastatic colorectal cancerVincenzo Mazzaferro, Jorgelina Coppa, Matteo G Carrabba, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 26, 2004
Boosting T cell-mediated immunity to tyrosinase by vaccinia virus-transduced, CD34(+)-derived dendritic cell vaccination: a phase I trial in metastatic melanomaMassimo Di Nicola, Carmelo Carlo-Stella, Roberta Mortarini, et al.
Journal of the National Cancer Institute|November 18, 2004
Effect of proton pump inhibitor pretreatment on resistance of solid tumors to cytotoxic drugsFrancesca Luciani, Massimo Spada, Angelo De Milito, et al.
Pageof 11